-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
January 01, 2010 - measures or performance metrics, especially when
gathered longitudinally over the long term, improves treatment … Outcome(s): Improvements in treatment results for patients (these results could be
measured using patient-centered … clinicians treat patients, and changes in the manner in which the healthcare system
approaches the treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Off-label intranasal oxytocin for treatment of autism
spectrum disorders
No high-impact potential … Presently, behavioral therapies and pharmaceutical treatments are
used to improve various symptoms … ES-3
Eligible Topic Not Deemed High Impact
Off-label intranasal oxytocin for treatment of autism
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
November 01, 2023 - Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review … Comparative Effectiveness Review
Number 266
Cervical Degenerative Disease
Treatment: A Systematic … 2
Background and Purpose
This systematic review identifies and synthesizes research on treatments … and 1980 for nonoperative
treatment to February 15, 2023. … Cervical Degenerative
Disease Treatment: A Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Better treatments to prevent COPD exacerbations are needed. … Although the cost of azithromycin therapy would be added to
current treatment costs, its low cost and … Available:
http://www.cff.org/treatments/CFCareGuidelines/.
30. Expert Commenter 665.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - Nonpharmacologic Therapies
Four small, short-term studies assessed nonpharmacologic
therapies in adults … One low-quality RCT evaluated
near-infrared light therapy compared with sham treatment. … However, adverse
effects of pharmacologic therapies and long-term treatment
withdrawals due to adverse … • Randomized trials of nonpharmacologic treatments
including herbal therapy, mind-body medicine, and … characteristics, such as disease
duration and previous therapy, affect
treatment outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
April 01, 2014 - Systematic review: nonoperative and operative
treatments for rotator cuff tears. … Systematic review:
nonoperative and operative treatments for rotator cuff tears. … Lipid-lowering
pharm therapy
overview
[4/7/2013]
J Treatment of
lipids -
secondary
prevention … Systematic review: nonoperative and
operative treatments for rotator cuff tears. … Allergic
rhinitis1
[7/24/2013]
Immuno-
therapy
Treatment for
Allergic
Rhinitis
[7/2013]
Allergen
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … unmet need for new therapeutic options for patients with IBS. … options, alternative therapies are needed. … FDA approves two therapies to treat IBS-D.
[internet]. Silver Spring (MD): U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
December 22, 2014 - market for HCV treatments. … The high cost of emerging HCV therapies combined with the large population
of patients requiring treatment … The high cost of emerging HCV therapies combined with the large
population of patients requiring treatment … Janssen Therapeutics. … Titusville (NJ): Janssen Therapeutics;
2014 Nov. 44 p.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Sovaldi and Sovaldi combination therapies. … of This Intervention
No FDA-approved vaccines or antiviral agents exist for EVD, although several therapeutic … SVR12 was 76% in patients naïve to treatment after 8 weeks of
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … Mesenchymal stem cell therapy for treatment of osteoarthritis
3. … = 0.043 and p = 0.010 respectively).
54
Autologous PRP is not currently considered a drug or a therapeutic … Gout therapeutics:
new drugs for an old disease. Lancet 2011 Jan
8;377(9760):165-77.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
August 31, 2017 - We have added a category for
parent based treatments. … Per Key Question 2, harms were
assessed for all treatments. … therapy consisted of. … psychotherapy” category due to the
significant theoretical and
methodological differences between
these therapeutic … how I would have classified
therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - myocardial infarction, and some
data suggest that women and men may not respond equally to the same treatments … ; and the fifth gap
(with its three subparts) looks at adverse effects that may occur due to these treatments … What are the risks, benefits, and costs of different treatments for CAD,
stratified by gender? … type, and the potential harms in women of different treatments for stable and unstable
angina. … Especially for patients treated with already
approved treatments and whose clinical care is not affected
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
September 01, 2010 - guidelines point to controversial areas in
need of future research, including: treatments to achieve … versus initial combination therapy, we will
collect data regarding prior therapy and will consider … analyzing those with and without prior
therapy separately. … OR azathioprine[tiab] OR methotrexate[tiab] OR “6-mercaptopurine”[tiab] OR
“antibodies, monoclonal/therapeutic … Prednisone
Prednisolone
6-methylpredisolone
Hydrocortisone
Budesonide
All trade names Oral, topical
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - therapeutic effects and better glycemic control. … The mode of
delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is
controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new
intervention just another treatment option … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … established for predicting development of dementia or other neurologic
condition or monitoring responses to therapies … this test is able to rule out AD), reduced need for long-
term care, and avoided use of ineffective therapies … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
November 19, 2012 - Testing and Treatment
Treatment for CUR is dependent on etiology. … , and pharmacologic treatments. … Table 1 lists the various surgical and
nonsurgical treatments for CUR. … silodosin); 5-Alpha Reductase Inhibitors (5-ARI): dutasteride, finasteride; AB + 5-
ARI combination therapy … duration
Setting Any treatment setting.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - Due to the large number of diseases for which HSCT is a treatment option (or experimental therapy … Given the cost of treatment,
the severity of diseases that HSCT is used to treat, and the prevalence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
February 01, 2013 - and between various nonoperative therapies. … , and between various nonoperative
therapies. … Operative
treatment
NSAID
Corticosteroid injection
Physical therapy
Modalities
Others … Treatments include but are not
limited to: exercise, manual
therapy, cortisone injections,
acupuncture … and between various nonoperative therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
January 01, 2010 - benzodiazepine receptor agonists, or antidepressants), complementary and alternative
care, relaxation therapy … , cognitive behavioral therapy, hormones
Comparator(s): Placebo or comparison to another insomnia … Treatment of chronic insomnia is a dilemma commonly encountered in primary care. … medications are most effective and when medications should be used as
opposed to nonpharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Because of even greater morbidity risk, therapeutic intervention is considered to
be urgently needed … In September 2014, FDA approved naltrexone-bupropion
(Contrave®, Orexigen Therapeutics, Inc., La Jolla … A
pathway to endoscopic bariatric therapies.
Gastrointest Endosc. 2011 Nov;74(5):943-53.